Answers are grounded in this paper and cite their sources.
Of all proposed cancer chemopreven-tive agents, p-carotene seemed the mostpromising (7)—until recently. Numer-ous retrospective and prospective studieshave demonstrated that a reduced risk oflung and other cancers is associatedwith an increased intake of provitaminA carotenoids, the vitamin A precursorsin vegetables and fruits (2-7). Inprospective studies, elevated prediag-nostic blood P-carotene levels havebeen consistently predictive of a re-duced incidence of lung and other can-cers (2-5,7,8). However, in a large,randomized, placebo-controlled trial inFinland (9), male smokers took P-carotene daily for 5-8 years at a dosesubstantially higher than that linked toreduced risk in observational studies,and lung cancer incidence was increased18% (95% confidence interval [CI] -3%-36%), contributing substantially toan 8% excess in total mortality. Interimresults from a second large, randomizedtrial conducted in the United States withmale and female smokers and men ex-posed to asbestos have corroborated thatlung cancer incidence and total mor-tality are increased in subjects taking P-carotene supplements.'The observational studies of diet andcancer relied on food composition tablesto estimate consumption of total pro-vitamin A carotenoids, which include p-carotene, a-carotene, and chemicallysimilar carotenoids. Recently, adatabase detailing the levels of themajor individual carotenoids in U.S.foods was published (10,11). Conse-quently, we reanalyzed data from thefirst case-control study to evaluate thehypothesis that P-carotene could protectagainst cancer—a population-basedstudy of diet and lung cancer conductedin New Jersey during 1980-1981(12,13).Eligible case subjects were whitemen
No takes yet. Share an insight, caveat, or question.
Ziegler et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: